COBE™, Seal Safe™, Spectra Optia™, and Trima Accel™ are either registered trademarks or trademarks of Terumo BCT, Inc. in the United States and/or other countries. See TerumoBCT.com/Trademarks for details.
Intended use
The Spectra Optia Apheresis System, a blood component separator, may be used to perform the following therapeutic apheresis, cell collection, and cell processing procedures:*
◼ Therapeutic plasma exchange
◼ Therapeutic plasma exchange with a secondary plasma device
◼ Red blood cell exchange, depletion, and depletion/exchange
◻ Red blood cell exchange, depletion, and depletion/exchange for the transfusion management of sickle cell disease in adults and children (U.S.)
◼ Mononuclear cell collection from the peripheral blood
◼ Granulocyte collection from the peripheral blood
◼ White blood cell depletion
◻ White blood cell reduction for patients with leukocytosis at risk for leukostasis (U.S.)
◼ Platelet depletion
◼ Processing of harvested bone marrow
◻ Processing of harvested bone marrow for the purpose of facilitating hematopoietic reconstitution (U.S.)
*Procedure availability varies by country
Sources for “Did You Know”:
Terumo Blood and Cell Technologies. Spectra Optia Apheresis System Operator’s Manual. Part no. 1000036875. August 2023.
Terumo Blood and Cell Technologies. COBE™ 2991 Cell Processor Essentials Guide. Part no. 1000081994. April 2025.
Sources for “Dear Access Point”:
Terumo Blood and Cell Technologies. Spectra Optia Apheresis System Operator’s Manual. Part no. 1000036875. August 2023.
Terumo Blood and Cell Technologies. Trima Accel™ Automated Blood Collection System Version 7.0 Operator’s Manual. Part No. 1000033112. November 2022.
Terumo Blood and Cell Technologies. Spectra Optia Operator's Manual. Part no. 1000001322. August 2023.